Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 65/100

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 ...

Key Takeaway: Penumbra, Inc. has announced that it will release its financial results for the fourth quarter and full year of 2022 on February 23, 2023, followed by a conference call at 4:30 PM Eastern Time. This event is part of Penumbra's commitment to communicate openly with investors regarding their financial performance. The conference call will be accessible by phone and through a webcast on their website, ensuring widespread access to the discussion. The company is recognized for its innovative medical therapies and operates globally in more than 100 countries.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of fourth quarter and full year 2022 earnings release
  • Hosting a conference call for investors signals transparency
  • Engagement with healthcare providers in over 100 countries

Full Press Release Details

ALAMEDA, Calif. , Jan. 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 after market close on Thursday, February 23, 2023 at 4:30 PM Eastern Time . A press release with fourth quarter and full year 2022 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
Source: Penumbra, Inc.
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

When will Penumbra announce its Q4 2022 financial results?

Penumbra will announce its Q4 2022 financial results on February 23, 2023.

How can I access the Penumbra conference call?

You can dial (888) 330-2443 or join the webcast on Penumbra's website.

What is Penumbra’s focus as a healthcare company?

Penumbra focuses on innovative therapies for challenging medical conditions.

How many countries does Penumbra operate in?

Penumbra supports healthcare providers in over 100 countries.

Where can I find more information about Penumbra?

More information is available on Penumbra's website and social media channels.

Last updated: Jan 26, 2023